New 450K-square-foot life science campus planned in Broomfield

Developer Scott Caldwell says life science companies needed this space "yesterday." Find out more in the Denver Business Journal article. A rendering of plans for Colorado Research ExchangeLINCOLN PRO...

Learn More

Umoja Biopharma Announces Activation of First ENLIGHTen Phase 1 Trial Site in Study of UB-TT170, a TumorTag that Targets Folate Receptors to Mark Tumors for Clearance by CAR T Cells

Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune cells in vivo for patients with solid and hematologic malignancies, announced...

Learn More

Brickell Biotech Announces Sale of Sofpironium Bromide to Botanix Pharmaceuticals

Brickell Biotech, Inc., a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of autoimmun...

Learn More

EvoEndo Poised to Transform Clinical Endoscopy Practice with the EvoEndo® Single-Use Unsedated Transnasal Endoscopy (TNE) System

EvoEndo®, Inc. (“EvoEndo”), a medical device company which developed a single use system that allows for unsedated Transnasal Endoscopy (TNE), has announced the completion of an $8.4 million Series A...

Learn More

CordenPharma Receives Supplier Recognition Award From Esperion

CordenPharma is honored to announce the receipt of a Supplier Recognition Award from Esperion Therapeutics that was presented by Esperion’s Sr. Vice President of Manufacturing Planning &...

Learn More

Allosource Recognized as the Top Colorado Bioscience Manufacturer

AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products to help surgeons heal their patients, has been recognized as 2022 Bioscience Manufactu...

Learn More

Edgewise-Funded Natural History Trial Of Becker Muscular Dystrophy (BMD) Now Enrolling

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for the treatment of rare muscle disorders, t...

Learn More

CEO Antoinette Gawin will serve as Group Managing Executive Officer in Terumo Corporation’s New Executive Officers’ Management System

Terumo Blood and Cell Technologies, a medical technology company, announces the appointment of Antoinette Gawin to serve as Group Managing Executive Officer (GMEO) for Terumo Corporation (TSE:4543)....

Learn More

Terumo Blood and Cell Technologies Appoints Gene Stellon to Lead Innovation and Development

Terumo Blood and Cell Technologies, a medical technology company, recently appointed Gene Stellon as Senior Vice President, Innovation and Development (I&D). He will serve on the Executive Managem...

Learn More

Gilead Jumps Out Ahead of BMS in Second-Line B-Cell Lymphoma

Kite Pharma, a subsidiary of Gilead, announced that Yescarta (axicabtagene ciloleucel), a chimeric antigen receptor (CAR) T-cell therapy, has been approved by the U.S. Food and Dru...

Learn More